Anti-inflammatory effects of ruxolitinib on chronic neutrophilic leukemia harboring CSF3R-T618I mutation with bilateral renal abscesses

[1]  A. Hochhaus,et al.  Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation , 2020, Annals of Hematology.

[2]  Philipp W. Raess,et al.  Efficacy of Ruxolitinib in Patients With Chronic Neutrophilic Leukemia and Atypical Chronic Myeloid Leukemia. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  A. Tefferi,et al.  Chronic neutrophilic leukemia: 2020 update on diagnosis, molecular genetics, prognosis, and management , 2019, American journal of hematology.

[4]  Giuseppe Alberto Palumbo,et al.  Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib , 2019, Front. Oncol..

[5]  Jun Liu,et al.  CSF3R T618I, ASXL1 G942 fs and STAT5B N642H trimutation co‐contribute to a rare chronic neutrophilic leukaemia manifested by rapidly progressive leucocytosis, severe infections, persistent fever and deep venous thrombosis , 2018, British journal of haematology.

[6]  D. Steensma,et al.  Clinical response to ruxolitinib in CSF3R T618-mutated chronic neutrophilic leukemia , 2016, Annals of Hematology.

[7]  J. Mascarenhas.  Selective Janus associated kinase 1 inhibition as a therapeutic target in myelofibrosis , 2015, Leukemia & lymphoma.

[8]  Angela G. Fleischman,et al.  Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. , 2013, The New England journal of medicine.

[9]  Jason Gotlib,et al.  A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis. , 2012, The New England journal of medicine.

[10]  Francisco Cervantes,et al.  JAK inhibition with ruxolitinib versus best available therapy for myelofibrosis. , 2012, The New England journal of medicine.

[11]  N. Nagata,et al.  Elevated neutrophil function in chronic neutrophilic leukemia , 1992, American journal of hematology.

[12]  D. Winfield,et al.  Cellular abnormalities and reduced colony-forming cells in chronic neutrophilic leukaemia. , 1985, Acta haematologica.

[13]  W. Pruzanski,et al.  Functional characterization of the cells in chronic neutrophilic leukemia , 1982, American journal of hematology.